Aleena Banerji, MD is a Professor of Medicine at Harvard Medical School and Clinical Director of Allergy and Immunology at MGH. Dr. Banerji received her MD from Northwestern University and completed her Allergy and Immunology fellowship training at MGH. Dr. Banerji is a clinical researcher in the field of drug allergy and angioedema with a focus on improving the quality of care for patients. She is also the Director of Clinical Care for the Center for Drug and Vaccine Allergy at MGH.

Mark S. Dykewicz, MD, FACAAI is a Raymond & Alberta Slavin-endowed professor in allergy & immunology, chief of allergy and immunology, professor of internal medicine and fellowship program director at Saint Louis University, a past recipient of the ACAAI distinguished Service Award and the AAAAI Special Recognition Award, his past service includes terms on the board of directors of the ABAI and AAAAI and Chair of the FDA Pulmonary Allergy Drug Advisory Committee.

Anne K. Ellis, MD, MSc, FACAAI is a Professor of Medicine and Chair of the Division of Allergy & Immunology at Queen’s University. She holds the James H. Day Chair in Allergic Diseases and Allergy Research. She is the Director of the Environmental Exposure Unit and the Allergy Research Unit at Kingston General Hospital. She is current President of the Canadian Society of Allergy and Clinical Immunology and serves on the Joint Task for Practice Parameters which represents the American Academy of Allergy, Asthma and Immunology as well as the American College of Allergy, Asthma and Immunology.

Mitchell H. Grayson, Grant Morrow, III, MD, FACAAI is the Grant Morrow, III, MD, Endowed Chair in Pediatric Research, director of theDivision of Allergy and Immunology, Nationwide Children's Hospital and professor of pediatrics, The Ohio State University, Columbus OH. He received his MD from the University of Chicago, undertook an internal medicine residency at the Hospital of the University of Pennsylvania, and completed an allergy-immunology fellowship at Johns Hopkins University. He studies the role of viruses in the development of allergic disease and asthma. He is the Editor-in-Chief of the Annals of Allergy, Asthma, and Immunology.

Matthew Greenhawt, MD, MBA, MSc, FACAAI is a Professor of Pediatrics, Allergy/Immunology Section, Children’s Hospital Colorado and the University of Colorado School of Medicine. A member of the AAAAI, ACAAI, and EAACI he is the senior associate editor for the Annals of Allergy, Asthma and Immunology, the immediate past chair of the ACAAI Food Allergy Committee, and a member of the Joint Task Force on Allergy Practice Parameters.

Jennifer R. Heimall, MD, FACAAI is the Elizabeth Paige Lavin Endowed Chair of Immunology Research and Clinical Care, fellowship training program director at the Children's Hospital of Philadelphia and associate professor of clinical pediatrics at Perelman School of Medicine at the University of Pennsylvania. She received her MD from New Jersey Medical School, where she also completed her Internal Medicine Pediatrics residency, followed by fellowship training at NIH. She is chair of the AAAAI Primary Immunodeficiency Committee and has served on CIS Executive Council. Her clinical research interests include atopic dermatitis and immunodeficiency, newborn SCID and long-term outcomes of hematopoietic stem cell transplant for immunodeficiencies.

John M. Kelso, MD, FACAAI received his MD from Saint Louis University. He completed residency in Pediatrics at Naval Medical Center in San Diego and fellowship in Allergy and Immunology at Mayo Clinic. He is in practice at Scripps Clinic in San Diego, where he is a Clinical Professor in the Division of Allergy, Asthma and Immunology. Dr. Kelso has authored over 130 publications, served on numerous society and editorial boards and is an author and Section Editor at UpToDate.

David A. Khan, MD, FACAAI is Professor of Medicine and Pediatrics at the University of Texas Southwestern Medical Center in Dallas. He has been the Program Director for the Allergy & Immunology fellowship program at Southwestern for over 25 years. Dr. Khan is a Past President of the AAAAI. He is a past recipient of the ACAAI Distinguished Fellow Award and the AAAAI Distinguished Clinician Award. He is currently an Associate Editor for the Journal of Allergy and Clinical Immunology In Practice. His research interests include drug allergy, therapies for refractory chronic urticaria, and the interaction of depression and asthma.

James T. Li, MD, PhD, FACAAI is a graduate of Princeton University and Duke Medical School. He is Professor of Medicine and a previous Chair of the Division of Allergic Diseases and Internal Medicine at Mayo Clinic Rochester. He is a previous President of the AAAAI, previous Chair of ABAI (American Board of Allergy and Immunology) and previous Chair of the Residency Review Committee for Allergy and Immunology (RRC-AI). Dr Li has published numerous articles, abstracts, and book chapters on anaphylaxis, asthma, drug allergy, and immunotherapy.

Kelly M. Maples, MD, FACAAI is a Professor of Pediatrics and Internal Medicine at Eastern Virginia Medical School and Old Dominion University and serves as full time faculty at Children’s Hospital of the King’s Daughters. Dr. Maples received her MD degree from Temple University School of Medicine and completed her allergy training at Virginia Commonwealth University. She is Treasurer of the ACAAI and previously served as chair of the ACAAI Dermatology Committee.

Anju T. Peters, MD is a Professor of Medicine and the Director of Clinical Research in the Division of Allergy Immunology at Northwestern University Feinberg School of Medicine. She is also the Medical Director of the Northwestern Medicine Clinical Research Unit and the Director of the Center for Clinical Research at the Northwestern University Clinical and Translational Sciences Institute. (NUCATS).

Punita Ponda, MD, FACAAI is an Associate Professor of Pediatrics and Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, and Associate Division Chief of Allergy and Immunology at Northwell Health. Dr. Ponda is the immediate past Chair of the Immunotherapy Allergen Standardization and Allergen Diagnostics Committee of the AAAAI and is part of the Joint Task Force on Practice Parameters Committee working on updating the Allergen Immunotherapy Practice Parameters. She is on the Editorial Board for the Annals of Allergy Asthma and Immunology and the Journal of Allergy and Clinical Immunology: In Practice. Her research efforts focus on learning the mechanisms of tolerance induction.